Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $29.2800 (-3.81%) ($28.8500 - $30.3300) on Tue. Sep. 8, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.63% (three month average) | RSI | 21 | Latest Price | $29.2800(-3.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -3.5% a day on average for past five trading days. | Weekly Trend | EDIT declines -5.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(62%) IWO(58%) ARKG(56%) IWC(55%) IBUY(54%) | Factors Impacting EDIT price | EDIT will decline at least -2.315% in a week (0% probabilities). VIXM(-28%) UUP(-14%) VXX(-12%) TBT(-7%) EDOC(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.315% (StdDev 4.63%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $21.99(-24.9%) | Resistance Level | $34.64 | 5 Day Moving Average | $32.58(-10.13%) | 10 Day Moving Average | $33.61(-12.88%) | 20 Day Moving Average | $34.64(-15.47%) | To recent high | -21.1% | To recent low | 17.1% | Market Cap | $1.818b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |